Skip to main content
. 2020 Oct 5;106(11):2845–2852. doi: 10.3324/haematol.2020.256388

Figure 1.

Figure 1.

Overall survival for patients with Hodgkin transformation. (A) Overall survival for patients with Hodgkin transformation (HT) who received prior chronic lymphocytic leukemia (CLL)-directed treatment versus no prior CLL-directed treatment. (B) Overall survival for patients with HT who received prior purine analogue (PA)- based therapy for CLL versus no prior PA-based therapy for CLL.